A general practitioner with over 20 years of experience has raised concerns about the severe health risks associated with unlicensed, black-market weight-loss drugs, specifically detailing the case of a patient who became seriously unwell after using a counterfeit version of the experimental drug retatrutide, nicknamed the 'Godzilla shot'.
The patient, identified as Jane, a 35-year-old mother of two, initially presented with severe vomiting that lasted for days. She also experienced intense nausea and constipation. After further questioning, Jane admitted to taking a black-market weight-loss drug called Reta, which she had obtained from a friend who purchased it online. She had injected the substance three times over three weeks.
Retatrutide, developed by Eli Lilly, is an experimental drug that has shown significant weight loss in trials, with patients losing up to a third of their body weight. However, it is not yet licensed for sale and cannot be legally dispensed. The doctor noted that illicit manufacturers appear to be producing their own versions of Reta, which are then sold through unregulated channels, such as online or via street dealers. The exact contents of these black-market vials are unknown and could vary significantly.
Jane's decision to try Reta stemmed from her long-standing struggle with being overweight, despite trying various diets and exercise regimens. The high cost of licensed weight-loss injections, approximately £200 per month, was prohibitive for her. Witnessing others achieve significant weight loss through these drugs on social media, she accepted the offer of free injections from a friend.
Despite her initial hopes, Jane's experience was ultimately disastrous. Three months after taking the drug, she continued to suffer from daily vomiting, persistent nausea, and missed periods. Her ability to eat remained severely impaired, further complicating her relationship with food and potentially causing permanent bodily damage.
The doctor expressed concern that Jane's case is not isolated. A recent survey indicated that a quarter of general practitioners have treated patients suffering severe illness from black-market weight-loss drugs. The accessibility of these substances was highlighted when the doctor, searching social media, found multiple individuals selling 'Reta' within minutes. Many individuals, predominantly women, are reportedly injecting themselves with these unregulated substances.
The situation is contrasted with a growing skepticism towards licensed pharmaceutical drugs, such as childhood vaccines and statins, often fueled by information found online. The doctor finds it paradoxical that people express caution regarding established medications while readily accepting untested drugs acquired through dubious online sources.
This trend also underscores the ongoing issue of restricted access to licensed weight-loss drugs within the UK's National Health Service (NHS). While over two million Britons pay for these treatments privately, fewer than 220,000 receive them through the NHS. The disparity in access is seen as a significant inequality that could lead to more patients resorting to dangerous black-market alternatives, driven by a desire for better health but ending up severely ill.